STOCK TITAN

Late 10-K puts IT Tech Packaging (NYSE: ITP) at risk of NYSE delisting

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

IT Tech Packaging, Inc. received a NYSE American notice of noncompliance after failing to file its Form 10-K for the year ended December 31, 2025 by the April 15, 2026 deadline. The company now enters a six-month Initial Cure Period, with a possible additional six-month extension, during which NYSE may commence suspension and delisting procedures if the delinquency is not cured. The notice does not immediately affect listing or trading, and the company plans to file the delinquent report within six months and aims to regain compliance, though there is no assurance this will occur.

Positive

  • None.

Negative

  • NYSE American noncompliance notice due to failure to file the Form 10-K for the year ended December 31, 2025 by the April 15, 2026 deadline, creating explicit suspension and delisting risk if the delinquency is not cured within permitted cure periods.

Insights

Late 10-K triggers NYSE noncompliance notice and delisting risk.

IT Tech Packaging has been cited by NYSE American for not filing its Form 10-K for the year ended December 31, 2025 by the April 15, 2026 deadline. This constitutes a filing delinquency under NYSE American continued listing standards.

The company now has an Initial Cure Period of six months from the delinquency date, with NYSE able to grant an Additional Cure Period of up to six months. NYSE also retains discretion to shorten or skip cure periods and start suspension and delisting procedures earlier under other guide provisions.

Management states it intends to file the delinquent report within the six-month window and regain compliance, but explicitly notes there is no assurance of success. Future company filings and NYSE determinations will clarify whether the listing remains on NYSE American or moves toward suspension and delisting.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice or transferred its listing to a different exchange.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Fiscal year of delinquent Form 10-K Year ended December 31, 2025 Period covered by the delinquent annual report
Form 10-K filing due date April 15, 2026 Deadline missed, creating the filing delinquency
Initial Cure Period length Six months Monitoring period from the filing delinquency date
Additional Cure Period length Up to six months Optional extension NYSE may grant at its discretion
Company founding year 1996 Year IT Tech Packaging was founded
NYSE American listing since December 2009 Date IT Tech Packaging became listed on NYSE American
Filing Delinquency regulatory
"due to the failure to timely file the Company’s Form 10-K ... (the “Filing Delinquency”)."
continued listing standards regulatory
"stating that the Company is not in compliance with NYSE American continued listing standards"
Ongoing rules a stock exchange requires a listed company to meet to keep its shares trading publicly, such as minimum share price, market value, timely financial reports, and governance practices. Think of it as a membership checklist for a club: falling short can lead to warnings or removal from the exchange, which can sharply reduce liquidity, investor confidence, and a stock’s value. Investors watch these standards to gauge regulatory risk and the stability of their holdings.
Initial Cure Period regulatory
"During the six-month period from the date of the Filing Delinquency (the “Initial Cure Period”)"
A specified window of time given to a party under a contract to fix a problem or comply with an obligation before the other side can take stronger steps like stopping performance, seeking damages, or terminating the agreement. For investors it matters because the length and conditions of that grace period affect how quickly disputes can escalate, the likelihood of contract continuity, and potential financial or operational disruptions—think of it as a formal grace period to repair a leak before deciding whether to replace the roof.
Additional Cure Period regulatory
"allow the Company’s securities to be traded for up to an additional six-month period (the “Additional Cure Period”)"
An additional cure period is extra time written into a contract that lets a party fix a breach or missed payment before the other side can take harsh steps like ending the deal or calling a loan due. For investors, it matters because it can delay or prevent immediate losses, affect the timing of recoveries, and signal how quickly negative events might hit a company’s cash flow or share value—like a grace period to repair a leaky pipe before eviction.
Form 12b-25 regulatory
"Reference is made to the Company’s Notification of Late Filing on Form 12b-25"
Form 12b-25 is a notice a publicly traded company files with the U.S. Securities and Exchange Commission when it cannot deliver a required periodic report (like a quarterly or annual financial report) on time. It explains the reason for the delay and gives the company a short, temporary window to finish the report without being marked as delinquent; investors watch it because late filings can signal accounting, operational, or control issues that may affect a company’s reliability and stock risk, much like a missed homework deadline can raise concerns about a student’s preparedness.
Regulation FD regulatory
"The information under this Item 7.01 ... is not intended to constitute a determination ... required by Regulation FD."
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
false 0001358190 0001358190 2026-04-16 2026-04-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): April 16, 2026

 

IT TECH PACKAGING, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other jurisdiction of incorporation)

 

001-34577   20-4158835
(Commission File Number)   (IRS Employer
Identification No.)

 

Science Park, Juli Road

Xushui District, Baoding City

Hebei Province, People’s Republic of China

  072550
(Address of principal executive offices)   (Zip Code)

 

(86312-8698215

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   ITP   NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On April 16, 2026, IT Tech Packaging, Inc., a Nevada corporation (the “Company”), received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2025 (the “Delinquent Report”) by the filing due date of April 15, 2026 (the “Filing Delinquency”).

 

The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the “Company Guide”). Within five days of the date of the Filing Delinquency Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release disclosing the occurrence of the Filing Delinquency, the reason for the Filing Delinquency and, if known, the anticipated date such Filing Delinquency will be cured via the filing or refiling of the applicable report, as the case may be. The NYSE American Notice has no immediate effect on the listing or trading of the Company’s common stock on NYSE American.

 

During the six-month period from the date of the Filing Delinquency (the “Initial Cure Period”), the NYSE will monitor the Company and the status of the Delinquent Report and any subsequent delayed filings, including through contact with the Company, until the Filing Delinquency is cured. If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the NYSE may, in the NYSE’s sole discretion, allow the Company’s securities to be traded for up to an additional six-month period (the “Additional Cure Period”) depending on the Company’s specific circumstances. If the NYSE determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 of the Company Guide. If the NYSE determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file its Delinquent Report and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.

 

Notwithstanding the foregoing, however, the NYSE may in its sole discretion decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may be, and immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision of the Company Guide, including if the NYSE believes, in the NYSE’s sole discretion, that continued listing and trading of the Company’s securities on the NYSE is inadvisable or unwarranted in accordance with Sections 1001-1006 of the Company Guide.

 

Reference is made to the Company’s Notification of Late Filing on Form 12b-25 (filed with the SEC on March 31, 2026), which described the circumstances leading to the late filing of the Delinquent Report. The Delinquent Report could not be filed within the prescribed time period due to the fact that the Company was unable to finalize its financial results as well as the disclosure requirements of the Delinquent Report without unreasonable expense or effort. As a result, the Company could not solicit and obtain the necessary review of the Delinquent Report in a timely fashion prior to the due date of the Delinquent Report. Additional time is needed by the Company to complete its review of the financial statements included in the Delinquent Report to ensure a complete, accurate Delinquent Report. The Company intends to file the Delinquent Report as soon as practicable and in any event within the six-month period.

 

The Company intends to regain compliance with the NYSE American continued listing standards. There can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing standards.

 

Item 7.01. Regulation FD Disclosure.

 

On April 20, 2026, the Company issued a press release announcing its receipt of the NYSE American Notice. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto, is material or that the dissemination of such information is required by Regulation FD.

 

1

 

 

Cautionary Statement Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains “forward-looking statements.” Any statements contained in this Current Report on Form 8-K that do not describe historical facts may constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “if,” “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology and include statements regarding the NYSE American Notice and whether the Company will regain compliance with the NYSE American’s continued listing standards. These forward-looking statements are based on information currently available to the Company’s management as well as estimates and assumptions made by its management and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Company’s or its industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. These forward-looking statements are made as of the date of this Current Report on Form 8-K, and the Company does not undertake an obligation to update these forward-looking statements after such date.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

The following exhibits are filed herewith:

 

Exhibit
Number
  Description
     
99.1   Press Release dated April 20, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  IT TECH PACKAGING, INC.
       
Date: April 20, 2026 By: /s/ Zhenyong Liu
    Name: Zhenyong Liu
    Title: Chief Executive Officer

 

3

 

Exhibit 99.1

 

IT Tech Packaging, Inc. Announces Receipt of Notice of Non-Compliance 

with NYSE Continued Listing Requirements

 

BAODING, China, April 20, 2026–(PRNewswire)– IT Tech Packaging Inc. (NYSE American: ITP) (“IT Tech Packaging” or the “Company”), a leading manufacturer and distributor of diversified paper products in North China, received an official notice of noncompliance (the “NYSE American Notice”) from NYSE Regulation (“NYSE”) stating that the Company is not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2025 (the “Delinquent Report”) by the filing due date of April 15, 2026 (the “Filing Delinquency”).

 

The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the “Company Guide”). Within five days of the date of the Filing Delinquency Notification, the Company was required to (a) contact the NYSE to discuss the status of the Delinquent Report and (b) issue a press release disclosing the occurrence of the Filing Delinquency, the reason for the Filing Delinquency and, if known, the anticipated date such Filing Delinquency will be cured via the filing or refiling of the applicable report, as the case may be. The NYSE American Notice has no immediate effect on the listing or trading of the Company’s common stock on NYSE American.

 

During the six-month period from the date of the Filing Delinquency (the “Initial Cure Period”), the NYSE will monitor the Company and the status of the Delinquent Report and any subsequent delayed filings, including through contact with the Company, until the Filing Delinquency is cured. If the Company fails to cure the Filing Delinquency within the Initial Cure Period, the NYSE may, in the NYSE’s sole discretion, allow the Company’s securities to be traded for up to an additional six-month period (the “Additional Cure Period”) depending on the Company’s specific circumstances. If the NYSE determines that an Additional Cure Period is not appropriate, suspension and delisting procedures will commence in accordance with the procedures set out in Section 1010 of the Company Guide. If the NYSE determines that an Additional Cure Period of up to six months is appropriate and the Company fails to file its Delinquent Report and any subsequent delayed filings by the end of that period, suspension and delisting procedures will generally commence.

 

Notwithstanding the foregoing, however, the NYSE may in its sole discretion decide (i) not to afford the Company any Initial Cure Period or Additional Cure Period, as the case may be, at all or (ii) at any time during the Initial Cure Period or Additional Cure Period, to truncate the Initial Cure Period or Additional Cure Period, as the case may be, and immediately commence suspension and delisting procedures if the Company is subject to delisting pursuant to any other provision of the Company Guide, including if the NYSE believes, in the NYSE’s sole discretion, that continued listing and trading of the Company’s securities on the NYSE is inadvisable or unwarranted in accordance with Sections 1001-1006 of the Company Guide.

 

Reference is made to the Company’s Notification of Late Filing on Form 12b-25 (filed with the SEC on March 31, 2026), which described the circumstances leading to the late filing of the Delinquent Report. The Delinquent Report could not be filed within the prescribed time period due to the fact that the Company was unable to finalize its financial results as well as the disclosure requirements of the Delinquent Report without unreasonable expense or effort. As a result, the Company could not solicit and obtain the necessary review of the Delinquent Report in a timely fashion prior to the due date of the Delinquent Report. Additional time is needed by the Company to complete its review of the financial statements included in the Delinquent Report to ensure a complete, accurate Delinquent Report. The Company intends to file the Delinquent Report as soon as practicable and in any event within the six-month period.

 

The Company intends to regain compliance with the NYSE American continued listing standards. There can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing standards.

 

 

 

About IT Tech Packaging, Inc.

 

Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP is located strategically close the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For more information, please visit: www.itpackaging.cn. 

 

Forward-Looking Statements

 

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company’s plan to file the Delinquent Report within the Initial Cure Period to regain compliance with the NYSE American continued listing standards. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Factors that may cause such differences include, without limitation, the Company’s ability to file the Delinquent Report within the Initial Cure Period to regain compliance with the NYSE American continued listing standards, and other risks and uncertainties indicated from time to time in filings with the Securities and Exchange Commission (“SEC”), including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, under the heading “Risk Factors,” and other documents the Company has filed, or will file, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

 

Contacts:

 

At the Company Email:

 

ir@itpackaging.cn
Tel: +86 0312 8698215

 

FAQ

Why did IT Tech Packaging (ITP) receive a NYSE American noncompliance notice?

IT Tech Packaging received the NYSE American notice because it failed to timely file its Form 10-K for the year ended December 31, 2025 by the April 15, 2026 due date. This filing delinquency violates NYSE American continued listing standards and triggered the noncompliance notification.

What are the potential consequences for IT Tech Packaging’s NYSE American listing?

The notice currently has no immediate effect on listing or trading. However, if IT Tech Packaging does not cure the filing delinquency within the six-month Initial Cure Period, and any allowed Additional Cure Period of up to six months, NYSE may commence suspension and delisting procedures under its company guide.

How long does IT Tech Packaging have to file its delinquent Form 10-K?

The company has an Initial Cure Period of six months from the filing delinquency date for NYSE to monitor progress on the delinquent Form 10-K. NYSE may, at its discretion, grant an Additional Cure Period of up to six months or shorten these periods based on specific circumstances.

What is IT Tech Packaging’s plan to address the NYSE American filing delinquency?

IT Tech Packaging states it intends to file the delinquent Form 10-K as soon as practicable and in any event within the six-month period. The company also intends to regain compliance with NYSE American continued listing standards, while cautioning there is no assurance it will ultimately succeed.

Does the NYSE American notice immediately affect trading in ITP stock?

The notice itself has no immediate effect on the listing or trading of IT Tech Packaging’s common stock on NYSE American. Trading may only be affected later if NYSE decides to commence suspension and delisting procedures because the company does not cure the filing delinquency within the applicable cure periods.

Why was IT Tech Packaging unable to file its Form 10-K on time?

The company explains it could not finalize financial results and disclosure requirements for the Form 10-K without unreasonable expense or effort. As a result, it could not complete necessary reviews of the report in time for the due date and requires additional time to ensure a complete, accurate filing.

Filing Exhibits & Attachments

4 documents